Skip to main content
Download PDF

Helicobacter pylori infection downregulates duodenal CFTR and SLC26A6 expressions through TGFβ signaling pathway

BMC Microbiology volume 18, Article number: 87 (2018) Cite this article

Abstract

Background

The pathogenesis of Helicobacter pylori (H. pylori) infection-induced duodenal ulcer remains to be elucidated. Duodenal mucosal bicarbonate secretion is the most important protective factor against acid-induced mucosal injury. We previously revealed that H. pylori infection downregulated the expression and functional activity of duodenal mucosal cystic fibrosis transmembrane conductance regulator (CFTR) and solute linked carrier 26 gene family A6 (SLC26A6) which are the two key duodenal mucosal epithelial cellular bicarbonate transporters to mediate duodenal bicarbonate secretion. In this study, we investigated the mechanism of H. pylori infection-induced duodenal CFTR and SLC26A6 expression downregulation.

Results

We found that H. pylori infection induced the increase of serum transforming growth factor β (TGFβ) level and duodenal mucosal TGFβ expression and the decrease of duodenal mucosal CFTR and SLC26A6 expressions in C57 BL/6 mice. The results from the experiments of human duodenal epithelial cells (SCBN) showed that H. pylori increased TGFβ production and decreased CFTR and SLC26A6 expressions in SCBN cells. TGFβ inhibitor SB431542 reversed the H. pylori-induced CFTR and SLC26A6 expression decreases. The further results showed that TGFβ directly decreased CFTR and SLC26A6 expressions in SCBN cells. TGFβ induced the phosphorylation of p38 mitogen-activated protein kinase (MAPK) and P38 MAPK inhibitor SB203580 reversed the TGFβ-induced CFTR and SLC26A6 expression decreases.

Conclusions

H. pylori infection downregulates duodenal epithelial cellular CFTR and SLC26A6 expressions through TGFβ-mediated P38 MAPK signaling pathway, which contributes to further elucidating the pathogenesis of H. pylori-associated duodenal ulcer.

Background

Duodenal ulcer is a common disease in the digestive tract [1, 2]. It has been demonstrated that Helicobacter pylori (H. pylori) infection is main etiologic agent responsible for duodenal ulcerogenesis [1, 3, 4]. In spite of extensive studies, the pathogenesis of H. pylori infection-induced duodenal ulcer remains to be elucidated.

Duodenal mucosal bicarbonate secretion is the most important protective factor against acid-induced duodenal mucosal injury [5, 6]. A clinical study showed that there was significant diminished duodenal mucosal bicarbonate secretion in the patients with H. pylori-associated duodenal ulcer in comparison with healthy controls, and duodenal mucosal bicarbonate secretion returned to normal levels after the eradication of H. pylori [7]. The studies from animal experiments showed that intraluminal perfusion of H. pylori water extract inhibited acid-stimulated duodenal mucosal bicarbonate secretion in rats [8]. Prostaglandin E2 (PGE2)-stimulated murine duodenal mucosal bicarbonate secretion in vitro was also strongly inhibited by water extract from cytotoxin-associated gen A (CagA) /vacuolating cytotoxin A (VacA)-positive H. pylori strains [9]. These studies suggest that the effect of H. pylori on duodenal mucosal bicarbonate secretion might be involved in the pathogenesis of H. pylori-associated duodenal ulcer. However, the mechanisms whereby H. pylori influences duodenal mucosal bicarbonate secretion are not completely understood.

Duodenal mucosal bicarbonate secretion is mediated by bicarbonate transporting proteins located in duodenal mucosal epithelial cells. The cystic fibrosis transmembrane conductance regulator (CFTR) and solute linked carrier 26 gene family A6 (SLC26A6) are the two key bicarbonate transporting proteins of duodenal mucosal epithelial cells and they play important role in the regulation of duodenal mucosal bicarbonate secretion [10,11,12]. We previously showed that H. pylori infection downregulated the expression and functional activity of duodenal mucosal CFTR and SLC26A6 [13], which contributes to the development of duodenal ulcer. In this study, we investigated the mechanism of H. pylori infection-induced duodenal CFTR and SLC26A6 expression downregulation. We hope to further elucidate the mechanisms whereby H. pylori infection influences duodenal mucosal HCO3− secretion and the pathogenesis of H. pylori infection-induced duodenal ulcer.

Methods

Reagents

Prostaglandin E2 (PGE2) and forskolin were purchased from Sigma. pH-sensitive fluorescent dye, 2′,7′-bis(2-carboxyethyl)-5(6)-carboxy-fluorescein acetoxymethyl ester (BCECF-AM), was from Invitrogen. Anti-CFTR, anti-SLC26A6, anti-P38, anti-phospho-P38, and anti-β-actin antibodies were from Santa Cruz. All other chemicals in solutions were obtained from Sigma and Calbiochem.

H. pylori strain

H. pylori strain (ATCC 43504), from the H. pylori Strain Pool, Beijing, China, was verified to be cytotoxin-associated gen A (CagA)- and vacuolating cytotoxin A (VacA)-positive previously [14] and used throughout the experiments. The CagA and VacA s1/s2 and m1/m2 genotypes of the H. pylori strain were further confirmed by specific polymerase chain reaction (PCR) as described previously by Miernyk et al. [15]. The H. pylori strain was routinely cultured for 48 h on Brucella agar plates containing 5% sheep blood at 37 °C under microaerophilic conditions in a humidified CO2 incubator (Thermo Fisher Scientific, Wilmington, DE) and then used for experiments.

H. pylori infection of mice

Male C57 BL/6 mice of 6 to 8 weeks from Shanghai Animal Center (Chinese Academy of Science, Shanghai, China) were used in this study. The animal experiments were approved by the Experimental Animal Ethics Committee of Zunyi Medical College and conducted in accordance with principles stated in the Guide for the Care and Use of Laboratory Animals (NIH publication 8623, National Institutes of Health, Bethesda, MD, 1985). The mice were housed in the experimental animal facility with specific pathogen free (SPF) of Zunyi Medical College under standard care conditions. 60 mice were used for H. pylori infection experiments and 10 mice were used as controls. After a week of acclimatization, the mice were orally gavaged with 0.5 ml H. pylori suspension in Brucella broth (1 × 109 CFU/ml) once daily for 4 consecutive days. The control mice were only gavaged with sterile Brucella broth. The mice were sacrificed by cervical dislocation under CO2 narcosis at 4 week after last gavage. Blood samples were quickly obtained by cardiac puncture for serum transforming growth factor β (TGFβ) level examination. The gastric antrum tissues were used for H. pylori infection examination. The duodenal mucosal tissues were used for examination of CFTR and SLC26A6 mRNA and protein expressions and TGFβ mRNA expression.

The presence of H. pylori in the stomach was determined by Giemsa-stained sections. H. pylori-negative was defined when Giemsa staining was determined to be negative by visual observation, and H. pylori-positive was defined when positive Giemsa staining was observed. H. pylori infection density was assessed by semiquantitative analysis of H. pylori levels in the gastric mucosa (+, less than 10 bacteria per gland; ++, 10 to 20 bacteria in at least one gland; +++, 20 to 30 bacteria in at least one gland; ++++, more than 30 bacteria in at least one gland).

H. pylori infection of duodenal epithelial cells

SCBN (a gift from Dr. Hui Dong in University of California San Diego) is a nontumorigenic duodenal epithelial cell line obtained from a human patient [16]. SCBN cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal calf serum and 50 mg/ml penicillin-streptomycin for two days. Then 5 × 106 SCBN cells were seeded on six-well plates and grown at 37 °C in a 5% CO2 atmosphere. Prior to infection, each well was washed twice in 1 ml of antibiotic-free cell culture medium. Then H. pylori was added to the cultured cells at different multiplicity of infection (MOI). After incubation for 24 h at 37 °C in a 5% CO2 atmosphere, the cells were harvested for examination of CFTR and SLC26A6 protein expression levels. The supernatants were for examination of TGFβ concentration. For intracellular pH measurement, SCBN cells were grown on 12-mm round coverslips and then incubated with H. pylori at a MOI value of 400 for 24 h. In addition, an uninfected control was included in each experiment.

Measurement of TGFβ concentration

For the measurement of serum TGFβ concentration, after blood was quickly obtained by cardiac puncture, the blood sample was centrifuged immediately at 3000 rpm for 5 min for collection of serum. The serum sample was stored at − 20 °C and analyzed within one week. Serum TGFβ level was detected by using the enzyme-linked immunosorbent assay kit (ELISA) (TGFβ1 Mouse Uncoated ELISA Kit, Invitrogen, USA, Cat. No. 88–50,690-22) according to the manufacturer’s instructions. TGFβ level in supernatant of H. pylori-infected SCBN cells was detected by using TGFβ1 Human Uncoated ELISA Kit (Invitrogen, USA, Cat. No. 88–50,390-77).

Quantitative real-time reverse transcription PCR analysis for mRNA expressions of CFTR, SLC26A6, and TGFβ

Total RNA extract of murine duodenal mucosal tissues and quantitative real-time reverse transcription PCR analysis were performed as described previously [17]. The mRNA expression level of CFTR, SLC26A6, or TGFβ was normalized to that of β-actin and was expressed as a ratio relative to β-actin. The primers were as follows: CFTR, forward 5′-AAGGCGGCCTATATGAGGTT-3′ and reverse 5′-AGGACGATTCCGTTGATGAC-3′; SLC26A6, forward 5′-GGTGGTGAAGCTGTTGAATGAC-3′ and reverse 5′-ATGTTGCCCACGACATCTACCTC-3′; TGFβ, forward 5′-ATACGCCTGAGTGGCTGTC-3′ and reverse 5′-GCCCTGTATTCCGTCTCCT-3′; β-actin, forward 5′-CTGCCTGACGGCCAAGTC-3′ and reverse 5′-CAAGAAGGAAGGCTGGAAAAGA-3′.

Western blot analysis for CFTR, SLC26A6, P38, and Phospho-P38 expressions

Murine duodenal mucosal tissues or SCBN cells were homogenized in lysis buffer at 4 °C and western blot analysis was performed as described previously [18]. Anti-CFTR, anti-SLC26A6, anti-P38, anti-Phospho-P38, or anti-β-actin (served as internal control) was used as primary antibody. The results were expressed as the ratio relative to β-actin.

Measurement of duodenal epithelial cellular bicarbonate secretion

Bicarbonate secretion in SCBN cells was determined through the measurement of intracellular pH [pHi] by using pH-sensitive fluorescent dye BCECF-AM as described previously [19]. When forskolin or PGE2 was used, forskolin (10 μM), PGE2 (1 μM), or control was added into solution. Stimulated duodenal epithelial cellular bicarbonate secretion was to stimulated peak pHi value minus basal pHi value and expressed as ∆pHi.

Statistics

Statistical analysis was processed by using the SPSS PC statistic package. All results are expressed as means ± standard errors (SE). Data were analyzed by one-way analysis of variance (ANOVA) followed by Newman-Keul’s post-hoc test or, when appropriate, by the two-tailed student t tests. P < 0.05 was considered statistically significant.

Results

Effect of H. pylori infection on CFTR, SLC26A6 and TGFβ expressions in murine duodenal mucosa and TGFβ level in murine serum

We first established H. pylori infection model in mice. Among 60 experimental mice, 19 (31.67%) were H. pylori (−), 17 (28.33%) were H. pylori (+), 11 (18.33%) were H. pylori (++), 8 (13.33%) were H. pylori (+++), and 5 (8.33%) were H. pylori (++++). The results from PCR and western blot analyses showed that the mRNA and protein expressions of duodenal mucosal CFTR and SLC26A6 in the mice with H. pylori (−) and (+) were not altered in comparison with controls, but there were markedly decrease in the mice with H. pylori (++), (+++), and (++++). The mRNA and protein expressions of duodenal mucosal CFTR and SLC26A6 were decreased with the severity of H. pylori infection (Fig. 1a and b). The further results showed that duodenal mucosal TGFβ mRNA expression in the mice with H. pylori (−) and (+) was not altered in comparison with controls and there were markedly increase in the mice with H. pylori (++), (+++), and (++++). The duodenal mucosal TGFβ mRNA expression was increased with the severity of H. pylori infection (Fig. 1c). H. pylori infection in the mice also induced serum TGFβ concentration increase. The change of serum TGFβ level was in consistent with the change of TGFβ expression in duodenal mucosa and serum TGFβ level was also increased with the severity of H. pylori infection (Fig. 1d). These results demonstrate that H. pylori infection decreases duodenal mucosal CFTR and SLC26A6 expressions and increases duodenal mucosal TGFβ expression, implying that duodenal mucosal CFTR and SLC26A6 decreases may be related to duodenal mucosal TGFβ increase.

Fig. 1
figure 1

Effect of H. pylori infection on CFTR and SLC26A6 mRNA and protein expressions and TGFβ mRNA expression in murine duodenal mucosa and murine serum TGFβ level. Murine H. pylori-infected model was established as described in experimental procedures. a: Effect of H. pylori infection on CFTR and SLC26A6 mRNA expressions in murine duodenal mucosa. b: Effect of H. pylori infection on CFTR and SLC26A6 protein expressions in murine duodenal mucosa. Upper panels are representative blots and lower panels are the comparisons of expression levels between groups. c: Effect of H. pylori infection on TGFβ mRNA expression in murine duodenal mucosa. d: Effect of H. pylori infection on murine serum TGFβ level. Values are mean ± SE in each series. Global P < 0.01; #P > 0.05, *P < 0.05, **P < 0.01 compared to controls

Full size image

Effect of H. pylori infection on CFTR and SLC26A6 expressions and TGFβ production in duodenal epithelial cells

We further selected human duodenal epithelial cells, SCBN, to do experiments and investigated the effect of H. pylori on CFTR and SLC26A6 expressions and TGFβ production in duodenal epithelial cells. As shown in Fig. 2, after incubation with SCBN cells for 24 h, H. pylori induced significant decrease of CFTR and SLC26A6 protein expressions in SCBN cells at a MOI value of 200 in comparison with controls and induced the maximal decrease at a MOI value of 400 (Fig. 2a). In addition, H. pylori induced TGFβ production increase in SCBN cells MOI-dependently. Likewise, H. pylori induced significant TGFβ production increase in SCBN cells at a MOI value of 200 in comparison with controls and induced the maximal increase at a MOI value of 400 (Fig. 2b). Forskolin, adenylate cyclase activator, is a known CFTR activator and stimulates duodenal mucosal bicarbonate secretion through CFTR, whereas PGE2 is believed to stimulate duodenal mucosal bicarbonate secretion mainly through SLC26A6 [20]. The further results showed that forskolin- and PGE2-stimulated bicarbonate secretions were markedly decreased in H. pylori-infected SCBN cells in comparison with controls (Fig. 3). TGFβ inhibitor SB431542 (10 μM) reversed H. pylori-induced CFTR and SLC26A6 protein expression decreases in SCBN cells (Fig. 4). These results indicate that H. pylori infection downregulates duodenal epithelial cellular CFTR and SLC26A6 expressions through TGFβ signaling.

Fig. 2
figure 2

Effect of H. pylori infection on CFTR and SLC26A6 protein expressions and TGFβ production in SCBN cells. SCBN cells were treated with different MOI of H. pylori for 24 h as described in experimental procedures. a: Effect of H. pylori infection on CFTR and SLC26A6 protein expressions in SCBN cells. Upper panels are representative blots and lower panels are the comparisons of expression levels between groups. b: Effect of H. pylori infection on TGFβ production in SCBN cells. Values are mean ± SE in each series. Global P < 0.01; #P > 0.05, *P < 0.05, **P < 0.01 compared to controls

Full size image
Fig. 3
figure 3

Effect of H. pylori infection on forskolin- and PGE2-stimulated bicarbonate secretion in SCBN cells. SCBN cells were treated with H. pylori at a MOI value of 400 for 24 h. The measurement of bicarbonate secretion in SCBN cells was performed as described in experimental procedures. a: Effect of H. pylori infection on forskolin- stimulated bicarbonate secretion in SCBN cells. Left panel is time course of change of forskolin-stimulated intracellular pH (pHi) in SCBN cells. Right panel is the comparison of ∆pHi. b: Effect of H. pylori infection on PGE2-stimulated bicarbonate secretion in SCBN cells. Left panel is time course of change of PGE2-stimulated intracellular pH (pHi) in SCBN cells. Right panel is the comparison of ∆pHi. Values are mean ± SE in each series. **P < 0.01 compared to controls

Full size image
Fig. 4
figure 4

Effect of TGFβ inhibition on H. pylori-induced CFTR and SLC26A6 protein expression decreases in SCBN cells. SCBN cells were treated with H. pylori at a MOI value of 400 for 24 h. TGFβ inhibitor SB431542 (10 μM) was added at 10 min before H. pylori. Upper panels are representative blots and lower panels are the comparisons of expression levels between groups. Values are mean ± SE in each series. #P > 0.05, **P < 0.01 compared to controls

Full size image

Effect of TGFβ on CFTR and SLC26A6 expression in duodenal epithelial cells

We further investigated whether TGFβ could regulate CFTR and SCL26A6 expressions in duodenal epithelial cells directly. As shown in Figs. 5 and 6, after TGFβ (5 ng/ml) incubated with SCBN cells for 24 h, CFTR and SLC26A6 protein expressions (Fig. 5) and forskolin- and PGE2-stimulated bicarbonate secretions (Fig. 6) in SCBN cells were markedly decreased in comparison with controls. The further results showed that TGFβ (5 ng/ml) induced the phosphorylation of P38 mitogen-activated protein kinase (MAPK) in SCBN cells after incubation with SCBN cells for 0.5 h and the maximal response was reached at 2 h (Fig. 7a). P38 MAPK inhibitor SB203580 (10 μM) markedly attenuated TGFβ-induced CFTR and SLC26A6 expression decreases in SCBN cells (Fig. 7b). The results demonstrate that TGFβ downregulates duodenal epithelial cellular CFTR and SLC26A6 expressions through P38 MAPK signaling pathway.

Fig. 5
figure 5

Effect of TGFβ on CFTR and SLC26A6 protein expressions in SCBN cells. SCBN cells were treated with TGFβ (5 ng/ml) for 24 h. Upper panels are representative blots and lower panels are the comparisons of expression levels between groups. Values are mean ± SE in each series. **P < 0.01 compared to controls

Full size image
Fig. 6
figure 6

Effect of TGFβ on forskolin- and PGE2-stimulated bicarbonate secretions in SCBN cells. SCBN cells were treated with TGFβ (5 ng/ml) for 24 h. The measurement of bicarbonate secretion in SCBN cells was performed as described in experimental procedures. a: Effect of TGFβ on forskolin-stimulated bicarbonate secretion in SCBN cells. Left panel is time course of change of forskolin-stimulated intracellular pH (pHi) in SCBN cells. Right panel is the comparison of ∆pHi. b: Effect of TGFβ on PGE2-stimulated bicarbonate secretion in SCBN cells. Left panel is time course of change of PGE2-stimulated intracellular pH (pHi) in SCBN cells. Right panel is the comparison of ∆pHi. Values are mean ± SE in each series. **P < 0.01 compared to controls

Full size image
Fig. 7
figure 7

Role of P38 MAPK in TGFβ-induced CFTR and SLC26A6 protein expression decreases in SCBN cells. SCBN cells were treated with TGFβ (5 ng/ml) for 24 h. P38 MAPK inhibitor SB203580 (10 μM) was added at 30 min before TGFβ. a: Effect of TGFβ on P38 phosphorylation in SCBN cells. Upper panels are representative blots and lower panels are time course of TGFβ-induced P38 phosphorylation. b: Effect of P38 MAPK inhibition on TGFβ-induced CFTR and SLC26A6 protein expression decreases in SCBN cells. Upper panels are representative blots and lower panels are the comparisons of expression levels between groups. Values are mean ± SE in each series. #P > 0.05, **P < 0.01 compared to controls

Full size image

Discussion

Duodenal mucosal bicarbonate secretion is the most important protective factor against acid-induced duodenal mucosal injury. In this study, we provide evidence that H. pylori infection downregulates the expressions of two key bicarbonate transport proteins, CFTR and SLC26A6, in duodenal epithelial cells through TGFβ-mediated P38 MAPK signaling pathway.

H. pylori is a Gram-negative bacterium and more than 50% of people were infected with H. pylori in the world [21]. It has been demonstrated that H. pylori infection is a major cause of duodenal ulcerogenesis [1, 3, 4]. However, the mechanisms whereby H. pylori infection causes duodenal ulcerogenesis are not completely understood. Previous studies revealed that H. pylori influenced duodenal mucosal bicarbonate secretion which might be involved in the pathogenesis of H. pylori-associated duodenal ulcer [7,8,9]. Our recent study further revealed that H. pylori infection downregulated CFTR and SLC26A6 expressions in human duodenal mucosal epithelial cells and the CFTR and SLC26A6 expression decreases were related to the severity and virulent factors of H. pylori infection [13]. But, how H. pylori influences CFTR and SLC26A6 is not clear. Several pathogenic mechanisms, including H. pylori virulence factors and host factors, have been associated with H. pylori-induced gastroduodenal diseases. In particular, the immune response against H. pylori virulence factors might provide a linkage to the development of gastroduodenal diseases [22,23,24]. Cytokines have long been considered as the main mediators of the immune response to H. pylori infection, which could modulate various intracellular signaling pathways and reprogram host gene expression [25, 26].

In this study, we hypothesized that H. pylori might regulate duodenal CFTR and SLC26A6 expressions through cytokines. First, we selected cytotoxin-associated gen A (CagA)- and vacuolating cytotoxin A (VacA)-positive H. pylori strain to establish murine H. pylori infection model. We found that H. pylori infection downregulated duodenal mucosal CFTR and SLC26A6 expressions in mice, which depended on the severity of H. pylori infection. On the other hand, H. pylori infection induced the increase of serum TGFβ level and duodenal mucosal TGFβ mRNA expression in the mice, which also depended on the severity of H. pylori infection. It suggested that a correlation might exist between CFTR and SLC26A6 expressions and TGFβ in duodenal mucosa. We further selected SCBN cells to perform experiments, because SCBN cells are nontransformed duodenal epithelial cells derived from humans and widely used for the study of bicarbonate secretion [14, 27]. The results showed that H. pylori increased TGFβ production and decreased CFTR and SLC26A6 expressions in SCBN cells, which depended on multiplicity of infection of H. pylori. Moreover, forskolin- and PGE2-stimulated bicarbonate secretions were markedly decreased in H. pylori-infected SCBN cells in comparison with controls. It has been demonstrated that forskolin stimulates duodenal mucosal bicarbonate secretion through CFTR and PGE2-stimulated duodenal mucosal bicarbonate secretion is SLC26A6-dependent [20]. The results further supported that H. pylori decreased duodenal epithelial cellular CFTR and SLC26A6 expressions. Further results showed that TGFβ inhibitor SB431542 reversed the H. pylori-induced CFTR and SLC26A6 expression decreases. After incubation with SCBN cells for 24 h, TGFβ directly decreased duodenal epithelial cellular CFTR and SLC26A6 expressions by itself and forskolin- and PGE2-stimulated bicarbonate secretions were also markedly decreased in TGFβ-treated SCBN cells in comparison with controls. Taken together, these results demonstrate that H. pylori downregulates duodenal epithelial cellular CFTR and SLC26A6 expressions through TGFβ signaling pathway.

TGFβ is a multifunctional cytokine that exerts a wide range of biological activities. TGFβ signaling regulates many different cell functions and critical cellular processes. Changes in cellular behavior are governed by activation of TGFβ rectors which triggers subsequent signaling pathways that change gene expression [28, 29]. Previous studies have provided evidence that TGFβ downregulates CFTR expression in polarized T84 human colonocytes and in primary human-airway epithelial cells [30,31,32]. As a cytokine, TGFβ can be induced through a number of cell types, such as macrophages and lymphocytes. H. pylori infection can cause the activation of immune cells, including macrophages, T cells, and B cells, leading to the production of cytokines. Previous studied have revealed that serum TGFβ level is elevated in patients with H. pylori-associated gastritis and peptic ulcers, in comparison with H. pylori-negative patients [33]. TGFβ mRNA expression is significantly increased in gastric mucosal biopsies of H. pylori-infected patients in comparison with H. pylori-uninfected patients [34]. In one study, H. pylori-secreted soluable proteins stimulated TGFβ production in gastric and colonic epithelial cells [35]. These studies indicate that H. pylori infection induces TGFβ production increase and TGFβ signaling might be involved in the pathogenesis of H. pylori-associated gastroduodenal diseases. In this study, our results showed that H. pylori infection increased TGFβ production and decreased CFTR and SLC26A6 expressions in duodenal epithelial cells. TGFβ inhibition reversed H. pylori infection-induced CFTR and SLC26A6 expression decreases, which demonstrates that H. pylori infection downregulates duodenal mucosal epithelial cellular CFTR and SLC26A6 expressions through TGFβ signaling, revealing the potential etiological role of TGFβ in H. pylori-associated duodenal ulcer.

How does TGFβ regulate duodenal mucosal epithelial cellular CFTR and SLC26A6 expressions? TGFβ is a complex signaling molecule that is activated when TGFβ binds to the TGFβ receptors, then leading to the activation and phosphorylation of the downstream mediators Smad proteins and regulating the expression of target genes in cooperation with other transcription factors, co-activators and co-repressors [28, 36]. In addition to Smad-dependent signaling, the binding of TGFβ to its receptors also activates many noncanonical signaling pathways, including p38 MAPK, external signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK) signaling pathways [37, 38]. In this study, our results showed that TGFβ induced the phosphorylation of P38 MAPK in SCBN cells and the inhibition of P38 MAPK reversed the TGFβ-induced CFTR and SLC26A6 expression decreases in SCBN cells, which demonstrates that TGFβ downregulates CFTR and SLC26A6 expressions in duodenal epithelial cells through P38 MAPK signaling pathway.

Conclusions

The findings from this study demonstrate that H. pylori infection downregulates duodenal epithelial cellular CFTR and SLC26A6 expressions through TGFβ-mediated P38 MAPK signaling pathway. CFTR and SLC26A6 are the two key bicarbonate transporters responsible for duodenal mucosal bicarbonate secretion. This study clarifies the mechanism whereby H. pylori infection induces duodenal epithelial cellular CFTR and SCL26A6 expression decreases and contributes to further elucidating the pathogenesis of H. pylori-associated duodenal ulcer.

Abbreviations

BCECF-AM:

2′,7′-bis(2-carboxyethyl)-5(6)-carboxy-fluorescein acetoxymethyl ester

CagA:

cytotoxin-associated gen A

CFTR:

cystic fibrosis transmembrane conductance regulator

H. pylori :

Helicobacter pylori

MAPK:

mitogen-activated protein kinase

PGE2 :

Prostaglandin E2

pHi:

intracellular pH

SLC26A6:

solute linked carrier 26 gene family A6

TGFβ:

transforming growth factor β

VacA:

vacuolating cytotoxin A

References

  1. Graham DY. History of helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol. 2014;20:5191–204.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Quan S, Frolkis A, Milne K, Molodecky N, Yang H, Dixon E, Ball CG, Myers RP, Ghosh S, Hilsden R, van Zanten SV, Kaplan GG. Upper-gastrointestinal bleeding secondary to peptic ulcer disease: incidence and outcomes. World J Gastroenterol. 2014;20:17568–77.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Schöttker B, Adamu MA, Weck MN, Brenner H. Helicobacter pylori infection is strongly associated with gastric and duodenal ulcers in a large prospective study. Clin Gastroenterol Hepatol. 2012;10:487–93.

    Article  PubMed  CAS  Google Scholar 

  4. Venerito M, Malfertheiner P. Interaction of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in gastric and duodenal ulcers. Helicobacter. 2010;15:239–50.

    Article  PubMed  CAS  Google Scholar 

  5. Allen A, Flemstrom G. Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am J Physiol Cell Physiol. 2004;288:C1–19.

    Article  CAS  Google Scholar 

  6. Said H, Kaji I, Kaunitz JD. Gastroduodenal mucosal defense mechanisms. Curr Opin Gastroenterol. 2015;31:486–91.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Hogan DL, Rapier RC, Dreilinger A, Koss MA, Basuk PM, Weinstein WM, Nyberg LM, Isenberg JI. Duodenal bicarbonate secretion: eradication of Helicobacter pylori and duodenal structure and function in humans. Gastroenterology. 1996;110:705–16.

    Article  PubMed  CAS  Google Scholar 

  8. Fandrinks L, Bothmer CV, Johansson B, Holm M, Bolin I, Pettersson A. Water extract of Helicobacter pylori inhibits duodenal mucosal alkaline secretion in anesthetized rats. Gastroenterology. 1997;113:1570–5.

    Article  Google Scholar 

  9. Tuo BG, Sellers ZM, Smith AJ, Barrett KE, Isenberg JI, Dong H. A role for CagA/VacA in Helicobacter pylori inhibition of murine duodenal mucosal bicarbonate secretion. Dig Dis Sci. 2004;49:1845–52.

    Article  PubMed  CAS  Google Scholar 

  10. Mount DB, Romero MF. The SLC26 gene family of multifunctional anion exchangers. Pflugers Arch. 2004;447:710–21.

    Article  PubMed  CAS  Google Scholar 

  11. Seidler U. Gastrointestinal HCO3 − transport and epithelial protection in the gut: new techniques, transport pathways and regulatory pathways. Curr Opin Pharmacol. 2013;13:900–8.

    Article  PubMed  CAS  Google Scholar 

  12. Sheppard DN, Welsh MJ. Structure and function of the CFTR chloride channel. Physiol Rev. 1999;79:S23–45.

    Article  PubMed  CAS  Google Scholar 

  13. Wen G, Jin H, Deng S, Xu J, Liu X, Xie R, Tuo B. Effects of Helicobacter pylori infection on the expressions and functional activities of human duodenal mucosal bicarbonate transport proteins. Helicobacter. 2016;21:536–47.

    Article  PubMed  CAS  Google Scholar 

  14. Ohkusa T, Okayasu I, Miwa H, Ohtaka K, Endo S, Sato N. Helicobacter pylori infection induces duodenitis and superficial duodenal ulcer in Mongolian gerbils. Gut. 2003;52:797–803.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Miernyk K, Morris J, Bruden D, McMahon B, Hurlburt D, Sacco F, Parkinson A, Hennessy T, Bruce M. Characterization of Helicobacter pylori cagA and vacA genotypes among Alaskans and their correlation with clinical disease. J Clin Microbiol. 2011;49:3114–21.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Pang G, Buret A, O’Loughlin E, Smith A, Batey R, Clancy R. Immunologic, functional, and morphological characterization of three new human small intestinal epithelial cell lines. Gastroenterology. 1996;111:8–18.

    Article  PubMed  CAS  Google Scholar 

  17. Xie R, Xu J, Wen G, Jin H, Liu X, Yang Y, Ji B, Jiang Y, Song P, Dong H, Tuo B. The P2Y2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP. J Biol Chem. 2014;289:19137–49.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Xu J, Xie R, Liu X, Wen G, Jin H, Yu Z, Jiang Y, Zhao Z, Yang Y, Ji B, Dong H, Tuo B. Expression and functional role of vacuolar H+-ATPase in human hepatocellular carcinoma. Carcinogenesis. 2012;33:2432–40.

    Article  PubMed  CAS  Google Scholar 

  19. Xu J, Ji B, Wen G, Yang Y, Jin H, Liu X, Xie R, Song W, Song P, Dong H, Tuo B. Na+/H+ exchanger 1, Na+/Ca2+ exchanger 1 and calmodulin complex regulates interleukin 6-mediated cellular behavior of human hepatocellular carcinoma. Carcinogenesis. 2016;37:290–300.

    Article  PubMed  CAS  Google Scholar 

  20. Tuo B, Riederer B, Wang Z, Colledge WH, Soleimani M, Seidler U. Involvement of the anion exchanger SLC26A6 in PGE2- but not forskolin-stimulated duodenal bicarbonate secretion. Gastroenterology. 2006;130:349–58.

    Article  PubMed  CAS  Google Scholar 

  21. Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter. 2015;19(Suppl 1):1–5.

    Google Scholar 

  22. Ibraghimov A, Pappo J. The immune response against Helicobacter pylori—a direct linkage to the development of gastroduodenal disease. Microbes Infect. 2000;2:1073–7.

    Article  PubMed  CAS  Google Scholar 

  23. Moyat M, Velin D. Immune responses to helicobacter pylori infection. World J Gastroenterol. 2014;20:5583–93.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Walduck A, Andersen LP, Raghavan S. Inflammation, immunity, and vaccines for helicobacter pylori infection. Helicobacter. 2015;20(Suppl 1):17–25.

    Article  PubMed  Google Scholar 

  25. Figueiredo CA, Marques CR, Costa Rdos S, da Silva HB, Alcantara-Neves NM. Cytokines, cytokine gene polymorphisms and helicobacter pylori infection: friend or foe? World J Gastroenterol. 2014;20:5235–43.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Li N, Xie C, Lu NH. Transforming growth factor-β: an important mediator in helicobacter pylori-associated pathogenesis. Front Cell Infect Microbiol. 2015;5:77.

    PubMed  PubMed Central  Google Scholar 

  27. Dong X, Ko KH, Chow J, Tuo B, Barrett KE, Dong H. Expression of acid-sensing ion channels in intestinal epithelial cells and their role in the regulation of duodenal mucosal bicarbonate secretion. Acta Physiol. 2011;201:97–107.

    Article  CAS  Google Scholar 

  28. Ikushima H, Miyazono K. TGFβ signalling: a complex web in cancer progression. Nature Rev. 2010;10:415–24.

    CAS  Google Scholar 

  29. Papageorgis P. TGFβ signaling in tumor initiation, epithelial-to-mesenchymal transition, and metastasis. J Oncol. 2015;587193.

  30. Howe KL, Wang A, Hunter MM, Stanton BA, McKay DM. TGFβ down-regulation of the CFTR: a means to limit epithelial chloride secretion. Exp Cell Res. 2004;298:473–84.

    Article  PubMed  CAS  Google Scholar 

  31. Snodgrass SM, Cihil KM, Cornuet PK, Myerburg MM, Swiatecka-Urban A. TGFβ1 inhibits Cftr biogenesis and prevents functional rescue of DeltaF508-Cftr in primary differentiated human bronchial epithelial cells. PLoS One. 2013;8:e63167.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Sun H, Harris WT, Kortyka S, Kotha K, Ostmann AJ, Rezayat A, Sridharan A, Sanders Y, Naren AP, Clancy JP. Tgf-beta downregulation of distinct chloride channels in cystic fibrosis-affected epithelia. PLoS One. 2014;9:e106842.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Shamsdin SA, Alborzi A, Rasouli M, Hosseini MK, Bagheri Lankrani K, Kalani M. Alterations in Th17 and the respective cytokine levels in helicobacter pylori-induced stomach diseases. Helicobacter. 2015;20:460–75.

    Article  PubMed  CAS  Google Scholar 

  34. Rahimian G, Sanei MH, Shirzad H, Azadegan-Dehkordi F, Taghikhani A, Salimzadeh L, Hashemzadeh-Chaleshtori M, Rafieian-Kopaei M, Bagheri N. Virulence factors of Helicobacter pylori vacA increase markedly gastric mucosal TGF-β1 mRNA expression in gastritis patients. Microb Pathog. 2014;67–68:1–7.

    Article  PubMed  CAS  Google Scholar 

  35. Wu MS, Lin JT, Hsu PN, Lin CY, Hsieh YT, Chiu YH, Hsueh PR, Liao KW. Preferential induction of transforming growth factor-beta production in gastric epithelial cells and monocytes by helicobacter pylori soluble proteins. J Infect Dis. 2007;196:1386–93.

    Article  PubMed  CAS  Google Scholar 

  36. Heldin CH, Moustakas A. Role of Smads in TGFβ signaling. Cell Tissue Res. 2012;347:21–36.

    Article  PubMed  CAS  Google Scholar 

  37. Gomes LR, Terra LF, Wailemann RA, Labriola L, Sogayar MC. TGFbeta1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells. BMC Cancer. 2012;12:26.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. McLean S, Bhattacharya M, Di Guglielmo GM. βarrestin2 interacts with TβRII to regulate Smad-dependent and Smad-independent signal transduction. Cell Signal. 2013;25:319–31.

    Article  PubMed  CAS  Google Scholar 

Download references

Funding

This work was supported by National Natural Science Foundation of China to B. Tuo (81160054), G. Wen (81460112), and P. Song (81272675 and 81570575). The funding body had no role in the design of the study and collection, analysis, and interpretation of data and in writing this manuscript.

Availability of data and materials

All data generated and/or analysed during this study are included in this published article. The raw data used and/or analysed during this study can be found in the computer of our laboratory, which are available from the corresponding author on reasonable request.

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Affiliated Hospital, Zunyi Medical College, 149 Dalian Road, Zunyi, 563003, China

    Guorong Wen, Shili Deng, Hai Jin, Jingyu Xu, Xuemei Liu, Rui Xie & Biguang Tuo

  2. Digestive Disease Institute of Guizhou Province, Zunyi, China

    Guorong Wen, Shili Deng, Hai Jin, Jingyu Xu, Xuemei Liu, Rui Xie & Biguang Tuo

  3. Clinical Medical Research Center of Guizhou Province for Digestive Diseases, Zunyi, China

    Guorong Wen, Shili Deng, Hai Jin, Jingyu Xu, Xuemei Liu, Rui Xie & Biguang Tuo

  4. Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

    Wenfeng Song & Penghong Song

  5. Collaborative innovation center for Diagnosis treatment of infectious diseases, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

    Wenfeng Song & Penghong Song

Authors
  1. Guorong Wen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shili Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wenfeng Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hai Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jingyu Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xuemei Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rui Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Penghong Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Biguang Tuo
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

GW, SD, WS, the acquisition and analysis of the data; HJ, JX, XL, RX, the acquisition of the data; PS, analysis of the data; BT, design of the study, analysis of the data, writing of the manuscript. All authors have read and approved the manuscript, and ensure that this is the case.

Corresponding author

Correspondence to Biguang Tuo.

Ethics declarations

Ethics approval

The animal experiments were approved by the Experimental Animal Ethics Committee of Zunyi Medical College and conducted in accordance with principles stated in the Guide for the Care and Use of Laboratory Animals (NIH publication 8623, National Institutes of Health, Bethesda, MD, 1985).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wen, G., Deng, S., Song, W. et al. Helicobacter pylori infection downregulates duodenal CFTR and SLC26A6 expressions through TGFβ signaling pathway. BMC Microbiol 18, 87 (2018). https://doi.org/10.1186/s12866-018-1230-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12866-018-1230-8

Keywords

  • Duodenal ulcer
  • Helicobacter pylori
  • CFTR
  • SLC26A6
  • TGFβ

BMC Microbiology

ISSN: 1471-2180

Contact us